Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2021-09-24 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the changes in shareholding by a significant shareholder (天津君睿祺股权投资合伙企业) in the listed company 成都市贝瑞和康基因技术股份有限公司. The content includes detailed information about the shareholder, the number of shares held before and after the change, the method of share reduction (including block trades and centralized bidding), and compliance with relevant laws and regulations. It also includes declarations and legal statements about the accuracy and completeness of the disclosure. There is no indication that this is an annual report, earnings release, or any other financial report. Instead, it is a formal notification of a change in major shareholding. According to the filing definitions, this fits the category of "Major Shareholding Notification (Code: MRQ)" which covers notifications of changes in significant share ownership levels crossing thresholds. The document length is substantial and contains detailed data, not just an announcement or a brief note, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is MRQ with high confidence.
2021-09-24 Chinese
关于持股5%以上股东股份减持计划实施时间过半的进展公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the progress of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the number of shares reduced, the methods of reduction, and the shareholder's compliance with relevant regulations. There is no financial data, earnings information, or report attached or referenced as being published. The content fits the description of a Major Shareholding Notification, specifically about changes in significant share ownership levels.
2021-09-22 Chinese
关于孕妇外周血胎儿游离DNA产前筛查纳入北京市医保的自愿性信息披露公告
Regulatory Filings Classification · 95% confidence The document is a voluntary information disclosure announcement by the company regarding the inclusion of a specific prenatal screening service into the Beijing medical insurance payment catalog. It discusses regulatory background, impact on the company, and risk warnings. The document is short (1334 characters) and does not contain financial statements or detailed financial data. It is an announcement about a regulatory or operational update rather than a financial report or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory or compliance announcements that do not fit other specific categories.
2021-09-02 Chinese
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Audit Report / Information Classification · 90% confidence The document is a special statement and independent opinion by independent directors regarding the company's controlling shareholders and related parties occupying company funds, and the company's external guarantees. It references regulatory notices from the China Securities Regulatory Commission and Shenzhen Stock Exchange listing rules. The content focuses on compliance and assurance about related party transactions and guarantees, rather than presenting financial statements or audit results. The document length is short (695 characters), and it is a formal statement by independent directors, which aligns with an Audit Report / Information type filing that includes applied accounting principles and regulatory compliance information but is not a full annual report or audit report itself. Therefore, the best fitting category is AR (Audit Report / Information). FY 2023
2021-08-29 Chinese
2021年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2021 年半年度报告摘要' which translates to '2021 Half-Year Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, total assets, and shareholder information for the half-year period. The presence of comprehensive financial metrics and discussion of company performance for a half-year period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2905 characters, which is relatively short but contains substantive financial data, not just an announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-29 Chinese
2021年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "成都市贝瑞和康基因技术股份有限公司 2021 年半年度报告全文," which translates to "Chengdu Berry Genomics Co., Ltd. 2021 Semi-Annual Report Full Text." It explicitly states it is a half-year report for the period 2021-01-01 to 2021-06-30. The content includes detailed financial data, management discussion and analysis, company business overview, accounting data, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. There is no indication that this is an announcement of a report publication or a certification letter. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.